EURACTIV PR

An easy way of publishing your relevant EU press releases.

“Ambition, vision and urgency for biotechnology”, EuropaBio reacts to the Biotechnology and Biomanufacturing Initiative

Date

21 Mar 2024

Sections

InfoSociety

Brussels, Belgium – 20 March 2024 - EuropaBio welcomes the Biotechnology and Biomanufacturing  Initiative, whilst calling for ambition and urgency in its implementation. The Initiative recognises that  biotechnology is one of the major global technologies shaping our health, food, and industrial  footprint with sustainability and resilience, whilst also significantly outperforming EU averages for  economic and employment growth. If Europe is to succeed, this Initiative has to rapidly transform  ‘rhetoric’ into policy and legislation action for competitiveness, enabling innovators to thrive and  grow, and creating long term investment into infrastructures, employment and skills in Europe. 

Whilst EuropaBio welcomes the positive start, it calls for immediate action to address many of the  bottlenecks that already create a drag on investment, scale up and market access, which in turn limit  citizen and economic benefits. Studies and reports tomorrow are not a replacement for action today,  especially when we can improve implementation of current regulations right now across EU and  Member States. The Initiative must also be more ambitious for investment growth, particularly for  scale up and technology maturation to market, and it must also be explicit and vocal on technologies  that it seeks to champion if the EU is to lead informed and engaged public narrative. 

Dr Claire Skentelbery, Director General of EuropaBio added “Ambition, vision and urgency are the calls  from EuropaBio for this promising initiative. The next Commission must combine long term vision and  bold ambitions with immediate and urgent attention to resolve existing barriers to growth. The world  is accelerating industrial outputs from biotechnology, and we need to move with it. EuropaBio will be  a partner and champion every step of the way to deliver Europe’s biotech future.” 

The Initiative potentially foresees a Biotech Act, which we also welcome, and rightly identifies the vital  components for success of such a cross-cutting frontier technology. Complex and opaque regulatory  pathways create a market pathway too slow, costly, and uncertain for investment, whilst the capital  market for scale up or clinical trials in Europe is weak. 

It is positive that the multi-Directorate Initiative recognises Europe’s need for a future-looking and  cross-cutting legislative framework built for biotechnology to streamline and remove obstacles in  existing regulations. EuropaBio welcomes the introduction of regulatory sandboxes and simplified,  accelerated pathways to market. Regulation must mature alongside innovation and is core to  successful industrial growth from Europe’s strong research base. In addition, an EU Biotech Hub will  provide welcome additional support for companies in navigating the complex and often overwhelming  regulatory framework.

Within industrial biotechnology, the proposed Product Environmental Footprint (PEF) review brings a  much-needed focus on the sustainability benefits from products through the assessment of fossil based and bio-based products to ensure equivalence; the recognition of the existing value across  sectors and the fundamental need for sustainable biomass, including primary biomass. This creates a  pathway for action throughout the value chain, from innovation to market and consumer. 

Within health biotech, the transformative nature of biotechnology and positive impact on health  systems are recognised. Many initiatives have already been adopted or proposed, and it is critical they  contribute towards the ambitious objective of European leadership for health biotech. Legislation  should focus on accelerating the translation of science into therapies, extending innovation capacity  for faster and wider patient access in the EU. 

EuropaBio is committed to work in partnership with policymakers and all interested parties to ensure  the EU can deliver on the objectives of this new Initiative.  

 

 

Jobs

EBF - European Banking Federation
Policy Adviser-Prudential Policy and Supervision
HYDROGEN EUROPE
HR Manager
Solar Power Europe
Office Coordinator
ECG-The Association of European Vehicle Logistics
Administration Officer